D.A. Davidson & Co. Adaptive Biotechnologies Corp Transaction History

D.A. Davidson & Co.

$12.2 Billion
Q1 2025

A detailed history of D.A. Davidson & Co. transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, D.A. Davidson & Co. holds 91,850 shares of ADPT stock, worth $676,016. This represents 0.01% of its overall portfolio holdings.

Number of Shares

91,850

Previous 88,450 3.84%

Holding current value

$676,016

Previous $530,000 28.68%

% of portfolio

0.01%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 28, 2025	BUY	$6.07 - $8.66 $20,638 - $29,444	3,400 Added 3.84%	91,850 $682,000
Q4 2024 Jan 31, 2025	BUY	$4.37 - $6.78 $29,388 - $45,595	6,725 Added 8.23%	88,450 $530,000
Q3 2024 Nov 13, 2024	SELL	$3.37 - $5.12 $15,165 - $23,040	-4,500 Reduced 5.22%	81,725 $418,000
Q2 2024 Jul 31, 2024	BUY	$2.34 - $3.96 $65,754 - $111,276	28,100 Added 48.34%	86,225 $312,000
Q1 2024 May 13, 2024	BUY	$2.88 - $4.8 $32,112 - $53,520	11,150 Added 23.74%	58,125 $186,000
Q4 2023 Feb 09, 2024	SELL	$3.46 - $5.33 $23,874 - $36,777	-6,900 Reduced 12.81%	46,975 $230,000
Q3 2023 Nov 08, 2023	SELL	$5.07 - $8.44 $149,058 - $248,135	-29,400 Reduced 35.3%	53,875 $293,000
Q2 2023 Aug 10, 2023	BUY	$6.19 - $8.78 $182,914 - $259,448	29,550 Added 55.0%	83,275 $558,000
Q1 2023 Apr 25, 2023	BUY	$7.8 - $10.11 $119,535 - $154,935	15,325 Added 39.91%	53,725 $474,000
Q4 2022 Feb 03, 2023	SELL	$6.26 - $9.34 $19,719 - $29,421	-3,150 Reduced 7.58%	38,400 $293,000
Q3 2022 Nov 07, 2022	BUY	$6.5 - $12.67 $9,002 - $17,547	1,385 Added 3.45%	41,550 $296,000
Q2 2022 Jul 28, 2022	BUY	$6.4 - $14.73 $98,368 - $226,400	15,370 Added 61.99%	40,165 $325,000
Q1 2022 May 12, 2022	BUY	$10.12 - $28.9 $69,322 - $197,965	6,850 Added 38.17%	24,795 $344,000
Q4 2021 Jan 31, 2022	BUY	$25.17 - $36.85 $29,197 - $42,746	1,160 Added 6.91%	17,945 $504,000
Q3 2021 Nov 15, 2021	BUY	$30.02 - $39.87 $26,267 - $34,886	875 Added 5.5%	16,785 $571,000
Q2 2021 Aug 10, 2021	BUY	$32.22 - $44.59 $16,915 - $23,409	525 Added 3.41%	15,910 $650,000
Q1 2021 May 07, 2021	BUY	$37.26 - $67.74 $176,985 - $321,765	4,750 Added 44.66%	15,385 $619,000
Q4 2020 Feb 10, 2021	SELL	$45.01 - $65.47 $4,501 - $6,547	-100 Reduced 0.93%	10,635 $629,000
Q3 2020 Nov 02, 2020	SELL	$35.79 - $48.81 $10,021 - $13,666	-280 Reduced 2.54%	10,735 $522,000
Q2 2020 Aug 10, 2020	SELL	$24.95 - $48.38 $134,106 - $260,042	-5,375 Reduced 32.79%	11,015 $533,000
Q1 2020 May 05, 2020	BUY	$16.96 - $34.16 $52,915 - $106,579	3,120 Added 23.51%	16,390 $455,000
Q4 2019 Feb 14, 2020	BUY	$24.56 - $32.8 $325,911 - $435,255	13,270 New	13,270 $397,000

Others Institutions Holding ADPT

# of Institutions

232

Shares Held

146M

Call Options Held

19.6K

Put Options Held

27.2K

View Full List

About Adaptive Biotechnologies Corp

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $1.05B
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

More about ADPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D.A. Davidson & Co., based on Form 13F filings with the SEC.

News

Stay updated on D.A. Davidson & Co. with notifications on news.

Account